Page last updated: 2024-11-05

tolbutamide and Carcinoid Tumor

tolbutamide has been researched along with Carcinoid Tumor in 1 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Carcinoid Tumor: A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schein, P1
Kahn, R1
Gorden, P1
Wells, S1
Devita, VT1

Other Studies

1 other study available for tolbutamide and Carcinoid Tumor

ArticleYear
Streptozotocin for malignant insulinomas and carcinoid tumor. Report of eight cases and review of the literature.
    Archives of internal medicine, 1973, Volume: 132, Issue:4

    Topics: Adenoma, Islet Cell; Adult; Blood Glucose; Carcinoid Tumor; Chemical and Drug Induced Liver Injury;

1973